A biotechnology company focused on the development of complex generic drugs, biosimilars, and novel therapies for immune-mediated diseases. Its research platform emphasized detailed structural analysis of biologic and complex molecules, supporting both partnered and proprietary drug programs. Invest...
2 members of Congress have disclosed 2 trades in Momenta Pharmaceuticals, Inc. (MNTA), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 2 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2020-09-25 | Christopher L. Jacobs | sell | $1K – $15K |
| 2015-05-27 | Thomas MacArthur | sell | $1K – $15K |